SCHWAB YIELDPLUS FD SELECT SHS
SymbolSWYSX

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

Charles Schwab Found Liable in YieldPlus FINRA Arbitration According to Aidikoff, Uhl & Bakhtiari - SCHW, SWYSX, SWYPX

2009-10-06 16:00 ET - News Release

Also News Release (U-SCHW) CHARLES SCHWAB CORP
Also News Release (U-SWYPX) SCHWAB YIELDPLUS FD INVESTOR SHS

BEVERLY HILLS, Calif., Oct. 6, 2009 (GLOBE NEWSWIRE) -- A Los Angeles based Financial Industry Regulatory Authority (FINRA) arbitration panel awarded damages to the Eliot family who invested in the Charles Schwab YieldPlus fund. The panel awarded the Eliot claimants approximately 125 percent of their net out of pocket losses. The panel also awarded expert witness costs and assessed the entire cost of the arbitration proceeding against Charles Schwab (Nasdaq:SCHW).

"We have now won the first six arbitration cases that have been presented to a panel of three arbitrators," said attorney Ryan K. Bakhtiari who was lead counsel. "Although Charles Schwab recommended the purchase of the Schwab YieldPlus Fund Select Shares (Nasdaq:SWYSX) and the Schwab YieldPlus Investor Shares (Nasdaq:SWYPX) (the 'YieldPlus Funds') as safe conservative cash alternatives to investors, the evidence established that the YieldPlus funds were over concentrated in mortgage backed securities."

The portfolio manager of the YieldPlus fund liquidated 2.9 million shares of the YieldPlus fund between January 31, 2008, and April 1, 2008, on behalf of certain Schwab Target retirement mutual funds that held YieldPlus. At the same time, Charles Schwab encouraged investors to hold YieldPlus and expressed confidence in the fund. "We are continuing to pursue FINRA arbitrations claims on behalf of investors who suffered losses in the YieldPlus Funds," added co-counsel Marnie Lambert.

The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try, click here for a free 30 day trial subscription.